BIOPHEN UFH Control Plasma

Incorrect product labeling was included in the package.

Recall #: Z-1743-2022
Affected scope: 13 units (1 unit is 1 box)
Initiated: June 28, 2022

Compiled from official public sources by the publisher. · Updated September 2026

Aniara Diagnostica LLC recalled BIOPHEN UFH Control Plasma - a low-severity action.

BIOPHEN UFH Control Plasma was recalled by Aniara Diagnostica LLC in September 21, 2022. Reason: Incorrect product labeling was included in the package.. Check the official notice for the remedy. Verify recall #Z-1743-2022 with the FDA Devices before acting.

The recall

Aniara Diagnostica LLC issued this low-severity FDA Devices recall-Incorrect product labeling was included in the package..

Low
severity level: Class III
classification: September 21, 2022
reported

Sourced from official FDA Devices enforcement records. Verify recall #Z-1743-2022 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This recall's affected scope, documented in the Recall Profile below, stays within a single-region or limited-distribution footprint. Distribution scope (see Distribution below) directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 6 from FDA Devices - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Where this agency-classified recall sits among FDA Class I/II/III notices

Of 88,244 recalls with an agency hazard classification, 19,068 are high severity, 64,652 moderate, and 4,524 low. A further 16,179 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified low severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Product description

BIOPHEN UFH Control Plasma

Reason for recall

Incorrect product labeling was included in the package.

Recall Profile

Structured summary of the FDA Devices recall record
Attribute	Value
Agency	U.S. Food and Drug Administration
Severity class	Low (Class III)
Status	Terminated
Recall number	Z-1743-2022
Date reported	September 21, 2022
Date initiated	June 28, 2022
Recalling firm	Aniara Diagnostica LLC
Firm location	West Chester, OH
Affected scope	13 units (1 unit is 1 box)
Distribution	Distribution in US - IL and MI

Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

Check the recall number (Z-1743-2022) and product description against the item you own. Search the archive
Confirm the current status with FDA Devices before acting, recall details can be updated.
Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled? ▼

BIOPHEN UFH Control Plasma. Recalled by Aniara Diagnostica LLC. Units affected: 13 units (1 unit is 1 box).

Why was this product recalled? ▼

Incorrect product labeling was included in the package.

Which agency issued this recall? ▼

This recall was issued by the FDA Devices on September 21, 2022. Severity: Low. Recall number: Z-1743-2022.

Where was the recalled product distributed? ▼

Distribution: Distribution in US - IL and MI.

Should I stop using a recalled medication or medical device? ▼

Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nationwide recalls with similar severity or category timing

Drug and device notices outside this firm and state, matched by severity timing and product category.

Similar severity · nearest report date

Same archive severity grade (Low), closest by report date among other firms and states.

GNC Vitamin B-6 100mg 100 VEGETARIAN TABL… 2022-09-21 Helix Elite Inactivated Standard, labeled… 2022-09-21 PTS Panels CHOL+GLU Test Strips (REF 1765) 2022-09-21 Clonidine Hydrochloride Tablets, USP, 0.3… 2022-09-28

Similar Medical Devices · nearest report date

Same product category, closest by report date among other firms and states (deduped against the severity set).

L-Carnitine 500 mg/mL Injectable, 10 ML v… 2022-09-21 MIC/B12 25/50/50/1 MG/ML Injectable, 10 M… 2022-09-21 MIC/B12/L-Carn (HD) 35/35/35/1/35 MG/ML I… 2022-09-21 Sermorelin Acetate 1 MG/ML Injectable, 9 … 2022-09-21

Compare this recall with GORE VIABIL Short Wire Biliary Endoprosthesis, Model No. VS… → · All Medical Devices recalls

This recall: FDA Devices, reported September 21, 2022. Severity classes follow each agency's own taxonomy; related-recall context is computed across the full archive.

Methodology · Corrections · Archive as of August 2026